Niu L, Hess G P
Section of Biochemistry, Molecular and Cell Biology, Cornell University, Ithaca, New York 14853-2703.
Biochemistry. 1993 Apr 20;32(15):3831-5. doi: 10.1021/bi00066a001.
When a neurotransmitter binds to its specific receptor, the protein forms transmembrane channels through which ions flow, leading to changes in transmembrane voltage that trigger signal transmission between neurons. How do inhibitors affect this process? Interesting and extensive information comes from investigations of the acetylcholine receptor, the best known of these proteins. This receptor is inhibited by cationic inhibitors, including local anesthetics, and acetylcholine at high concentrations. The accepted mechanism, elegant in its simplicity, is that these compounds enter the receptor-channel after it opens and block inorganic ion flux. This mechanism requires that the inhibitors affect only the apparent rate constant for channel closing (k'cl). An alternative mechanism invokes a specific regulatory (inhibitory) site to which inhibitors bind before the channel opens and the signal is transmitted. This mechanism requires that the inhibitors affect the apparent rate constants for both channel opening (k'op) and closing. The effect of inhibitors on k'op has not been determined previously. This report describes the use of a newly developed laser-pulse photolysis technique with a dead time of approximately 120 microseconds to determine the effect of a local anesthetic, procaine, one of the best studied cationic inhibitors of the acetylcholine receptor, on both k'op and k'cl. Both k'op and k'cl were found to decrease with increasing procaine concentration. This effect of the inhibitor of k'op cannot be explained by the open-channel-blocking mechanism but is consistent with the existence of a regulatory (inhibitory) receptor site.
当神经递质与其特定受体结合时,该蛋白质会形成跨膜通道,离子通过这些通道流动,导致跨膜电压发生变化,从而触发神经元之间的信号传递。抑制剂是如何影响这一过程的呢?有趣且丰富的信息来自对乙酰胆碱受体的研究,这类蛋白质中最知名的就是它。该受体受到阳离子抑制剂的抑制,包括局部麻醉药以及高浓度的乙酰胆碱。公认的机制简单而巧妙,即这些化合物在通道打开后进入受体通道并阻断无机离子通量。这种机制要求抑制剂仅影响通道关闭的表观速率常数(k'cl)。另一种机制则涉及一个特定的调节(抑制)位点,抑制剂在通道打开和信号传递之前就与之结合。这种机制要求抑制剂影响通道打开(k'op)和关闭的表观速率常数。此前尚未确定抑制剂对k'op的影响。本报告描述了使用一种新开发的激光脉冲光解技术,其死时间约为120微秒,来确定局部麻醉药普鲁卡因(乙酰胆碱受体研究得最为充分的阳离子抑制剂之一)对k'op和k'cl的影响。结果发现,随着普鲁卡因浓度的增加,k'op和k'cl均降低。抑制剂对k'op的这种影响无法用开放通道阻断机制来解释,但与存在调节(抑制)受体位点是一致的。